Naobios
Overview and capabilities of Naobios
Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.
In the news
See all newsDiscover our team:
Ysaline Roland, Production manager at Naobios
Our newest series of articles promote the people that make up our company and its human-centric values and objectives. Our latest profile is dedicated to Ysaline Roland, Production Manager at Naobios.
Collaboration
Naobios signs Service Agreement with Nobelpharma
Naobios will rely on its 15 years of expertise in process development and GMP manufacturing to support Nobelpharma develop its product. Naobios collaborated last year with the Japan-based company on preliminary studies.
Clean Biologics was born in 2018 from a fruitful alliance between Clean Cells and Archimed. Through this partnership, the group soon acquired and integrated CDMO Naobios to extend the service offer and to promote our future-oriented thinking. The expertise, transparency, progress and a human-centred view are at the core of our identity. Day after day, we use our knowledge and our skills to deliver high-quality services in innovative projects with an unwavering dynamism and commitment.
Over 15 Years
History in GMP and Process Development Activities
A team
of 40 people